Teva to Report First Quarter 2014 Financial Results on May 1, 2014

  Teva to Report First Quarter 2014 Financial Results on May 1, 2014

Business Wire

JERUSALEM -- March 20, 2014

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will
release its first quarter 2014 financial results on Thursday, May 1, 2014 at
7:00 a.m. ET.

Teva will host a conference call and live webcast on the same day, at 8:00
a.m. ET to discuss its first quarter 2014 results and overall business
environment. A Question & Answer session will follow this discussion.

In order to participate, please dial the following numbers (at least 10
minutes before the scheduled start time): United States and Canada
1-888-771-4371; International 1-847-585-4405; passcode: 36926391.

A live webcast of the call will also be available on Teva's website at:
www.tevapharm.com. Please log in at least 10 minutes prior to the conference
call in order to download the applicable audio software.

Following the conclusion of the call, a replay of the webcast will be
available within 24 hours on the Company's website. The replay can also be
accessed until May 8, 2014, at 11:59 p.m. ET by calling 1-888-843-7419 or
1-630-652-3042; passcode: 36926391#.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic drugs as
well as innovative and specialty pharmaceuticals and active pharmaceutical
ingredients. Headquartered in Israel, Teva is the world's leading generic drug
maker, with a global product portfolio of more than 1,000 molecules and a
direct presence in approximately 60 countries. Teva's Specialty Medicines
businesses focus on CNS, respiratory oncology, pain, and women's health
therapeutic areas as well as biologics. Teva currently employs approximately
45,000 people around the world and reached $20.3 billion in net revenues in
2013.

Contact:

IR:
Kevin C. Mannix, United States, 215-591-8912
Ran Meir, United States, 215-591-3033
Tomer Amitai, Israel, 972 (3) 926-7656
or
PR:
Iris Beck Codner, Israel, 972 (3) 926-7246
Denise Bradley, United States, 215-591-8974
 
Press spacebar to pause and continue. Press esc to stop.